Harm from delayed administration of rasburicase for tumour lysis syndrome
Prevent delays in administering rasburicase for tumour lysis syndrome. Ideally given within one hour in high-risk cases.
Source · National Patient Safety Alerts
HOMERTON HEALTHCARE NHS FOUNDATION TRUST
RQX ODS code
LONDON region
3 open alerts
2 Sep 2026 CAS snapshot
National Patient Safety Alerts recorded as open for this trust after their completion deadline had passed, drawn from the MHRA Central Alerting System compliance report of 2 September 2026. That report names only organisations past a deadline, so it records neither compliance nor the position since that snapshot.
Open alerts for this trust
Shortage of dinoprostone 3mg vaginal tablets and 1mg/2.5ml, 2mg/2.5ml vaginal gel
Risk associated with adult breathing circuits lacking a patent exhalation route
Develop local guidance for assembling breathing circuits, implement staff training on safety checks.
Data source
Data from the MHRA Central Alerting System compliance report of 2 September 2026, which lists alerts that had passed their completion deadline and remained open at that date. The Central Alerting System does not publish a list of compliant organisations, and the report says nothing about the position since that snapshot.